Iguratimod tablets 25 mg | IBRUNITIME 25

Description

IBRUNITIME 25 is a prescription medicine containing Iguratimod Tablets 25 mg, a disease-modifying anti-rheumatic drug widely used in the management of autoimmune and inflammatory joint disorders. Iguratimod works by targeting the underlying inflammatory processes rather than just masking symptoms, making it an important option in long-term treatment plans for patients suffering from chronic joint conditions. IBRUNITIME 25 is developed to support better joint function, reduce inflammation, and improve overall quality of life when used under medical supervision. Uses Iguratimod Tablets 25 mg are primarily prescribed for the treatment of inflammatory and autoimmune joint disorders. Common uses include: Management of rheumatoid arthritis Reduction of joint pain, swelling, and stiffness Control of chronic inflammation associated with autoimmune conditions Support in slowing disease progression in inflammatory joint diseases Doctors may prescribe IBRUNITIME 25 alone or in combination with other anti-rheumatic medicines based on the patient’s condition and response. Benefits IBRUNITIME 25 offers multiple therapeutic benefits for patients with chronic inflammatory disorders: Helps reduce joint inflammation and swelling Improves joint mobility and daily functioning Supports long-term disease control rather than short-term pain relief May slow down joint damage associated with rheumatoid arthritis Enhances overall comfort and quality of life with regular use By addressing the immune-mediated inflammatory response, Iguratimod helps patients manage symptoms more effectively over time. Dosage The dosage of Iguratimod Tablets 25 mg should be strictly followed as advised by a healthcare professional. Usually taken orally with water May be taken with or after food to reduce gastric discomfort Dosage frequency depends on the severity of the condition and individual response Patients should not alter the dose or discontinue IBRUNITIME 25 without consulting their doctor, as consistent use is important for optimal results. Side Effects Like all medicines, IBRUNITIME 25 may cause some side effects, although not everyone experiences them. Possible side effects include: Nausea or stomach discomfort Mild diarrhea Dizziness or headache Elevated liver enzymes in some patients Skin reactions in rare cases Most side effects are mild and temporary. However, if any unusual or persistent symptoms occur, medical advice should be sought immediately. Precautions and Warning Before using Iguratimod Tablets 25 mg, patients should inform their doctor about their complete medical history. Important precautions include: Regular monitoring of liver function as advised by the physician Caution in patients with liver disorders Not recommended during pregnancy and breastfeeding unless clearly prescribed Avoid alcohol consumption, as it may increase the risk of liver-related side effects Inform the doctor about all other medicines being taken to prevent interactions IBRUNITIME 25 should be used only under medical supervision. Conclusion IBRUNITIME 25, containing Iguratimod Tablets 25 mg, is a reliable and effective option for managing rheumatoid arthritis and other inflammatory joint disorders. By targeting the root cause of inflammation, it helps reduce symptoms, improve joint function, and support long-term disease control. When used as prescribed and monitored regularly, IBRUNITIME 25 can play a valuable role in improving patient outcomes and enhancing overall quality of life.